Carticept Medical Inks $10M

Carticept Medical Inc., a developer of treatments for cartilage injuries and osteoarthritis, has raised $10 million in financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc. The money is aimed at commercial launch of the company’s computer-controlled drug delivery system. In total, Carticept has raised $53 million from investors.

18 January 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail